NCT06471790

Brief Summary

Freedom of movement and the ability to walk are crucial during the first stage of labor, potentially reducing labor duration, cesarean section risk, epidural analgesia use, and bladder catheterization. While the clinical effects of ambulation during labor remain controversial, there is a consensus on its positive impact on the birthing experience and satisfaction. Epidural analgesia remains the gold standard for pain control during labor, with a utilization rate of 82% in France. Recent advancements in obstetric analgesia have allowed for lower doses of analgesics, often administered via patient-controlled analgesia, which maintains the potential for ambulation during labor. However, only a small number of maternity units in France offer this technique. The main barriers include organizational issues such as unsuitable facilities, lack of wireless telemetry, and potential risks such as falls and hypotension. Significant changes in gait characteristics are observed throughout pregnancy, particularly during the third trimester, and are studied in laboratory settings using video capture and analysis. Gait during labor is influenced by pain, fetal progression, and anatomical changes in the pelvis. The presence of epidural analgesia, where local anesthetics likely affect neural transmission, may impact motor commands and sensory feedback, further altering gait characteristics. These biomechanical aspects of labor remain understudied. Wearable inertial sensors show promise in maternal health monitoring by providing real-time data for motion and gait studies. However, their application has not been described or validated during labor, particularly in walking conditions. Continuous dynamic study of gait in these conditions could enable non-invasive, non-intrusive monitoring of analgesia effectiveness, fall risk prediction, and labor progression analysis. The aim of this feasibility study is to validate the use of wearable inertial sensors to quantify movements and characterize gait during the first stage of labor, both with and without low-dose epidural analgesia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
2mo left

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Nov 2024Jul 2026

First Submitted

Initial submission to the registry

June 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

November 11, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2026

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1.7 years

First QC Date

June 18, 2024

Last Update Submit

January 16, 2026

Conditions

Keywords

PREGNANCYLABOREPIDURAL ANALGESIAWALKING EPIDURALMOVEMENTSGAITINERTIAL SENSOR

Outcome Measures

Primary Outcomes (1)

  • triaxial (x, y, z) velocity changes over time unit (dV/dt) = m/s2 (meter over square second)

    gait patterns derived from accelerometer data measuring acceleration in three axes (x, y, z)

    during walking starting from the demand of the parturient to have an epidural up to delivery

Study Arms (1)

Walking Epidural Analgesia for Labor

Pregnant women in labor who benefit from walking epidural analgesia technique will be monitored using inertial wearable sensors beginning from the first stage of labor and up to delivery.

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

at-term (\>= 38 gestation weeks) women admitted to the maternity facility for labor and delivery and willing low dose epidural analgesia with walking option

You may qualify if:

  • pregnancy \>= 38 gestation weeks
  • no significant medical history (American Society of Anesthesiologists class ASA 1)
  • receiving low-dose epidural analgesia with ambulation (in accordance with current service protocol)
  • not opposed to the study

You may not qualify if:

  • Refusal to participate in this study
  • Non-French-speaking patient
  • History of osteoarticular pathology likely to change gate (severe scoliosis, spinal surgery, congenital hip deformity, pelvic fracture, ligament or knee joint pathology)
  • adults under legal protection
  • multiple pregnancy
  • need for continuous intravenous infusion with infusion stand during ambulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital de la Croix Rousse

Lyon, 69004, France

RECRUITING

MeSH Terms

Conditions

HeadacheObstetric Labor Complications

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Mikhail PH DZIADZKO, MD

    Anesthésie Réanimation Douleur

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 24, 2024

Study Start

November 11, 2024

Primary Completion (Estimated)

July 12, 2026

Study Completion (Estimated)

July 12, 2026

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations